Pulmonary tularaemia in a female adolescent with inflammatory bowel disease receiving infliximab: Do not miss the diagnosis

Abstract

We report the first described case of pulmonary tularaemia in the pediatric patient receiving infliximab for ulcerative colitis. We highlight the importance of considering Francisella tularensis in diagnostically challenging cases of persistent respiratory symptoms to facilitate early diagnosis and adequate therapy.

The TCR-γδ (+) DN T cells are gaining important role in clinical practice. Polymerase chain reaction assays and serology guarantee early recognition.

Keywords

• double negative T-lymphocytes
• infliximab
• paediatrics
• pulmonary tularaemia
• ulcerative colitis